AstraZeneca calls pitch for cholesterol drug Crestor in Hong Kong
HONG KONG - Global pharmaceutical company AstraZeneca has called an integrated agency pitch for its cholesterol-lowering drug Crestor and has already started pitch meetings, with the result expected in Q4.
by Benjamin Li
Sign In
Trouble signing in?